Endocrinological Assessment in Transgender Individuals

    October 2022 in “ Springer eBooks
    Carlotta Cocchetti, Mario Maggi, Alessandra D. Fisher
    Image of study
    TLDR The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.
    The document "The Transgender: Endocrinological Assessment" discusses the role of endocrinologists in gender-affirming treatment for transgender individuals, emphasizing the need for personalized clinical approaches. It reviews hormonal treatment strategies for both binary and non-binary transgender people, detailing the expected body modifications and safety profiles of available compounds. For trans AFAB individuals, testosterone administration can lead to increased facial and body hair, body composition changes, voice deepening, and in some cases, androgenetic alopecia. For trans AMAB individuals, oestrogens can induce female secondary sexual characteristics, including a significant reduction of terminal facial and body hair, increased body fat, and breast development. The document also discusses the use of finasteride for treating androgenetic alopecia and hirsutism, and the use of topical minoxidil for beard development. It concludes by emphasizing the need for more research on non-standardized therapies for non-binary individuals.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results